The FDA has also raised concerns about unapproved GLP-1 products, including: Incorrect dosing or measurement Concentration differences between pharmacies Use of unapproved semaglutide salt forms Products containing too much or too little active ingredient Fraudulent or improperly labelled products Adverse events related to compounded injections Patients should confirm the pharmacy name, drug concentration, prescribed dose and measurement instructions before administering each shipment
Changes in insulin regimen may result in hyperglycemia or hypoglycemia
Understanding where you are in this schedule, and what your corresponding units should be at 5mg/ml, is critical for both safety and effectiveness
This guide provides the framework for doing that intelligently
Carnitine is generally well tolerated, and adverse effects have rarely been reported in research studies
The National Institutes of Health confirms its role in reducing oxidative stress (NIH, 2023)